6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0059 762-25-1-040-0124 -Tucson CMOP ATORVASTATIN CALCIUM -(VA-25-00015524)
ID: 36C77025Q0059Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/c946d0135cb44a5c9609e019ccaf2dce/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Atorvastatin Calcium 80mg tablets to be delivered to its Tucson CMOP facility. This contract is specifically set aside for small businesses and requires compliance with the Buy American statute, necessitating separate quotes for foreign and domestic products. The pharmaceuticals are critical for the healthcare of veterans, emphasizing the importance of responsible sourcing and regulatory compliance in the pharmaceutical supply chain. Interested vendors must submit their proposals via email to Jeffrey Blackard by December 26, 2024, at 09:00 AM Central Time, with the anticipated award date set for December 30, 2024.

    Point(s) of Contact
    Jeffrey A BlackardTCF Intern
    jeffrey.blackard@va.gov
    Files
    Title
    Posted
    36C77025Q0059_1.docx
    The document serves as a Request For Proposals (RFP) from the Department of Veterans Affairs (VA) for pharmaceutical supplies. It outlines the requirements for vendors wishing to bid, including key stipulations about product specifications, delivery logistics, and necessary documentation to ensure compliance with federal regulations. The proposal emphasizes the need for U.S.-made products and adherence to the Drug Supply Chain Security Act (DSCSA). Vendors are required to provide a signed SF 1449 cover page, a price schedule in Excel format, and a State Wholesale Distributor License. The contract stipulates details regarding delivery to specific locations, invoicing processes, and compliance with various regulations, including those related to equal opportunity and payment processes. It also highlights requirements for affirmation of product availability and pricing, as well as conditions for product recalls. Overall, the document functions as a detailed guide for potential suppliers, ensuring that they understand the expectations and legal frameworks governing the contracting process with the VA. This reflects broader government efforts to maintain regulatory compliance and quality assurance in federal procurement practices.
    36C77025Q0059.docx
    The Department of Veterans Affairs is soliciting proposals for the procurement of pharmaceuticals, specifically Atorvastatin Calcium in 80mg tablets, to be delivered to its Tucson CMOP facility. The contract is set-aside for small businesses, with responses due by December 26, 2024, at 09:00 AM Central Time. Vendors must comply with the Buy American statute and provide separate quotes for foreign and domestic products. Along with their price submissions in Excel format, vendors are required to submit a signed solicitation cover page, a state wholesale distributor license validating compliance with the Drug Supply Chain Security Act (DSCSA), and the Buy American Certificate. This solicitation underscores the need for responsible sourcing and adherence to regulatory compliance in the pharmaceutical supply chain. The award is anticipated on December 30, 2024, and all proposals must be submitted via email to the designated contact person, Jeffrey Blackard. Interested parties are encouraged to monitor changes on the sam.gov website, where the solicitation will be posted.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The file details the Buy American Certificate requirements for federal procurement. The Offeror must certify that all end products are domestic, except those listed as foreign, and ensure that domestic products contain critical components. It outlines stipulations for foreign end products, including mandatory reporting of their country of origin and whether they exceed 55% domestic content. A distinct list is required for domestic end products with critical components. The government evaluates submissions according to the Federal Acquisition Regulation guidelines. This document underscores the importance of promoting domestic manufacturing and ensuring transparency in government contracting. Compliance with these requirements is critical for Offerors seeking to engage in federal contracting opportunities.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0059.xlsx
    This document outlines a Request for Quote (RFQ) from the VA concerning the purchase of Atorvastatin Calcium 80mg tablets. The RFQ (36C77025Q0059) is set to be issued on December 20, 2024, with a closing date of December 26, 2024, at 9:00 AM CST. The estimated award date is December 30, 2024, and delivery is expected by January 14, 2025. Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory; suppliers must provide documentation confirming state wholesale distributor licensure along with their quote. Failure to submit this document will render submissions technically unacceptable. Required documentation for quote submission includes an SF1449 form, a price schedule in Excel format, proof of state licensure, and a completed Buy American certificate. The proposal must be sent via email to designated VA procurement addresses relevant to various CMOP sites. This procurement emphasizes adherence to regulatory standards governing prescription drug distribution and ensures proper safety and compliance during the acquisition process. The overall aim is to secure a reliable supplier for pharmaceutical needs while maintaining stringent compliance with federal regulations.
    Similar Opportunities
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Omeprazole DR capsules, structured into two distinct groups: Group 1 for various package sizes of 20mg and 40mg capsules, and Group 2 for bulk quantities of these capsules. The procurement aims to establish reliable supply sources for pharmaceuticals through the VA Pharmaceutical Prime Vendor Program and the Pharmaceutical Repackaging Program, ensuring consistent availability and compliance with regulatory standards. Interested offerors must submit pricing for both groups, adhering to specific packaging and labeling requirements, with the deadline for submissions extended to December 27, 2024, at 2:30 PM CST. For further inquiries, potential bidders can contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.